Summary
Molecular analyses allow one to determine genetic lesions occurring early in the development of tumors. With positional cloning approaches we are searching for a gene involved in the development of early onset familial breast and ovarian cancer that maps to human chromosome 17q21 and is termed BRCA1. This involves localizing the region genetically within families with multiply affected members, capturing the region identified by genetic analyses in YACs (yeast artificial chromosomes), converting those YACs to smaller manipulable pieces (such as cosmids), and searching for genes via a variety of approaches such as direct screening of cDNA libraries with genomic clones, direct selection by hybridization, “exon trapping”, and CpG island rescue. Once identified, candidate genes will be screened for mutations in affected family members in whom breast cancer segregates with the locus on 17q21. The frequency of this gene has been calculated to be 0.0033; from this the incidence of carriers, i.e. those carrying such a predisposition, is one in 150 women. The isolation of BRCA1 and the elucidation of the mutations resulting in breast and ovarian cancer predisposition will allow identification of women who have inherited germ-line mutations in BRCA1. In families known to harbor a germ-line BRCA1 mutation, diagnosis of affected members will be rapid. It is possible that one will also be able to detect alterations of the second copy of this gene early in tumor development in individuals carrying a germ-line mutation. It is not yet known how frequently somatic BRCA1 mutations predispose to breast and ovarian carcinoma in the general female population. If, as in other genetic diseases, new germ-line mutations occur in some women and thus contribute to the development of breast cancer, it may be feasible to screen women in the general population for predisposing mutations. In addition, if acquired genetic mutations of the BRCA1 gene are involved as early events in the development of non-familial forms of the disease, early detection of possible breast carcinoma may become feasible in biopsy of breast tissue.
Similar content being viewed by others
References
Anderson L, Friedman L, Osborne-Lawrence S, et al: High-density genetic map of the BRCA1 region of chromosome 17q12-q21. Genomics 17:618–641, 1993
Ashton-Rickardt PG, Dunlop MG, Nakamura Y, Morris RG, Purdie CA, Steel CM, Evans HJ, Bird CC, Wyllie AH: High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene 4:1169–1174, 1989
Bates G, Valdes J, Hummerich H, Baxendale S, Le Paslier D, Monaco A, Tagle D, MacDonald M, Altherr M, Ross M, Brownstein B, Bentley D, Wasmuth J, Gusella J, Cohen D, Collins F, Lehrach H: Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region. Nature Genet 1:180–187, 1993
Bird A: CpG islands as gene markers in the vertebrate nucleus. Trends Genet 3:342–347, 1987
Bishop J, Morton J, Rosebach M, Richardson M: Three abundance classes in HeLa cell messenger RNA. Nature 250:199–204, 1974
Bowcock A, Anderson L, Black D, Osborne-Lawrence S, Hall J, King M-C: THRA1 and D17S183 flank an interval of < 4cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet 52:718–722, 1993
Buckler A, Chang D, Graw S, et al: Exon amplification: A strategy to isolate mammalian genes based on RNA splicing. Proc Natl Acad Sci USA 88:4005–4009, 1991.
Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S, Nordenskjold M: Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968–1972, 1990
Chumakov IF, Rigault P, Guillou S, Ougen P, Billaut A, Guasconi G, et al: Continuum of overlapping clones spanning the entire human chromosome 21q. Nature 359:380–387, 1992
Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232–242, 1991
Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS: Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592–595, 1979
Cotton RG, Rodrigues NR, Campbell RD: Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci USA 85:4397–4401, 1988
Cox DR, Burmeister M, Price ER, Kim S, Myers RM: Radiation hybrid mapping: a somatic cell genetic method for constructing high resolution maps of mammalian chromosomes. Science 250:245–250, 1990
Duyk G, Kim S, Myers R, Cox D: Exon trapping: A genetic screen to identify candidate transcribed sequences in cloned mammalian genomic DNA. Proc Natl Acad Sci USA 87:8995–8999, 1990
Easton DF, Bishop T, Ford D, Crockford GP: The Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678–701, 1993
Fontaine B, Sanson M, Delattre O, Menon AG, Rouleau GA, Seizinger BR, Jewell AF, Hanson MP, Aurias A, Martuza RL, et al: Parental origin of chromosome 22 loss in sporadic and NF2 neuromas. Genomics 10:280–283, 1991
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56, 1990
Futreal PA, Söderqvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW: Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52:2624–2627, 1992
Galau G, Klein W, Britten R, Davidson E: Significance of rare mRNA sequences in liver. Arch Biochem Biophys 179:584–599, 1977
Green ED, Olson MV: Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction. Proc Natl Acad Sci USA 87:1213–1217, 1990
Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Yoslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, LePaslier D, Abderrahim H, Cohen D, Leppert M, White R: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600, 1991
Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689, 1990
Herrera L: Gardner's syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25:473–476, 1986
Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease. Cell 72:971–983, 1993
Jelinek WR: Ubiquitous interspersed repeated sequences in mammalian genomes. Proc Natl Acad Sci USA 77:1398–1402, 1980
Kelsey JL: A review of the epidemiology of human breast cancer. Epidemiol Rev 1:74–109, 1979
Kovacs G, Szucs S, De Riese W, Baumgartel H: Specific chromosome aberration in human renal cell carcinoma. Cancer Res 40:171–178, 1987
Ledbetter SA, Nelson DL, Warren ST, Ledbetter DH: Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. Genomics 6:475–481, 1990
Lovett M, Kere J, Hinton L: Direct selection: A method for the isolation of cDNAs encoded by large genomic regions. Proc Natl Acad Sci USA 88:9628–9633, 1991
Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238, 1990
Margaritte P, Bonaiti-Pellie C, King M-C, Clerget-Darpoux F: Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease: Am J Hum Genet 50:1231–1234, 1992
Milner R, Lai C, Lenoir D, Nave K, Bakhit C, Malfroy B: Brain-specific gene expression. Biochem Soc Symp 52:107–117, 1986
Myers RM, Sheffield VC, Cox DR: Detection of single base changes in DNA: ribonuclease cleavage and denaturing gradient gel electrophoresis.In: Davies K (ed) Genome Analysis: A Practical approach. IRL Press, 1988, pp 95–130
Narod S, Feunteun J, Lynch H, et al: Familial breastovarian cancer locus on chromosome 17q12-q23. Lancet 338:82–83, 1991
Newman B, Austin M, Lee M, King M: Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044–3048, 1988
Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preisinger AC, Smith KJ, Su L, Kinzler KW, Vogelstein B: Mutations of chromosome 5q21 genes in FAP patients and colorectal cancer patients. Science 253:665–669, 1991
Olson M, Hood L, Cantor C, Botstein D: A common language for physical mapping of the human genome. Science 245:1434–1435, 1989
Ohlsson R: Growth factors, proto-oncogenes and human placental development. Cell Diff Dev 28:1–15, 1989
Okubo K, Hori N, Matoba R, et al: Large-scale cDNA mapping for analysis of quantitative and qualitative aspects of gene-expression. Nature Genet 2:173–179, 1992
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766–2770, 1989
Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874–879, 1989
Parimoo S, Patanjali S, Shukla H, Chaplin D, Weismann S: cDNA selection: efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc Natl Acad Sci USA 88:9623–9627, 1991
Pathak S, Strong LC, Ferrell RE, Trindade A: Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science 217:939–941, 1982
Ponder BAH: Gene losses in human tumours. Nature 335:400–401, 1988
Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555–7559, 1990
Rommens JM, Iannuzzi MC, Kerem B, Drunn ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui L-C, Collins FS: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065, 1989
Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184–7189, 1990
Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51:5794–5799, 1991
Saito H, Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y: Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53:3382–3385, 1993
Schwartz DC, Cantor CR: Separation of yeast chromosome-sized DNAs by pulsed-field gradient gel electrophoresis. Cell 37:67–75, 1984
Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, Anderson KM, Freiman RN, Whaley J, et al: Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci USA 88:2864–2868, 1991
Simard J, Feunteun J, Lenoir G, Tonin P, Normand T, Luu The V, Vivier A, Lasko D, Morgan K, Rouleau GA, Lynch H, Labrie F, Narod SA: Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Molec Genet 2:1193–1199, 1993
Slamon DJ, Godolphin W, Jones LA, et al: Studies of the HER-2/neu oncogene. Science 235:177–182, 1989
Smith S, Easton D, Evans D, Bonder B: Allele losses in the region 17q12-q21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet 2:128–131, 1992
Tsui LC: The spectrum of cystic fibrosis mutations [review]. Trends in Genetics 8:392–398, 1992
Trask BJ: Fluorescencein situ hybridization: applications in cytogenetics and gene mapping. Trends in Genetics 7:149–154, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bowcock, A.M. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Res Tr 28, 121–135 (1993). https://doi.org/10.1007/BF00666425
Issue Date:
DOI: https://doi.org/10.1007/BF00666425